Naproxen
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 22204-53-1
Synonym(S): (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1457301-200-MG | In Stock | ₹ 46,222.75 |
1457301 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 46,222.75
GST (18%): ₹ 8,320.095
Total Price: ₹ 54,542.845
grade
pharmaceutical primary standard
API family
naproxen
manufacturer/tradename
USP
technique(s)
HPLC: suitablegas chromatography (GC): suitable
mp
152-154 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O
InChI
1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
InChI key
CMWTZPSULFXXJA-VIFPVBQESA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-15030 500mg Medchemexpress, Naproxen CAS:22204-53-1 Purity:>98% | -- | ₹ 4,672.50 | ||
Sigma Aldrich Fine Chemicals Biosciences Naproxen British Pharmacopoeia (BP) Reference Standard | 22204-53-1 | MFCD00010500 | | -- | ₹ 24,857.70 | ||
Naproxen Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 13,857.30 | ||
Sigma Aldrich Fine Chemicals Biosciences Naproxen European Pharmacopoeia (EP) Reference Standard | 22204-53-1 | MFCD00010500 | | -- | ₹ 24,531.07 | ||
Naproxen | -- | ₹ 12,935.88 | ||
Naproxen | -- | ₹ 9,580.13 | ||
Naproxen | -- | ₹ 20,794.83 | ||
(S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid | -- | ₹ 7,999.68 - ₹ 9,147.13 | ||
Naproxen | -- | ₹ 1,157.00 - ₹ 18,779.00 | ||
22204-53-1 | (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid | -- | ₹ 1,513.00 - ₹ 18,779.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Naproxen USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Biochem/physiol Actions: Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P202 - P273 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3